Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
85 hedge funds and large institutions have $63.9M invested in Avid Bioservices, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 25 reducing their positions, and 6 closing their positions.
183% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 6
34% more call options, than puts
Call options by funds: $513K | Put options by funds: $383K
15% more funds holding
Funds holding: 74 → 85 (+11)
1% more capital invested
Capital invested by funds: $63.1M → $63.9M (+$767K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$749K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$485K |
| 3 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$417K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$340K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$331K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.22M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$861K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$259K |
| 4 |
Morgan Stanley
New York
|
-$220K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$208K |
CDMO Hedge Fund Activity: Q2 2014 in Review
85 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2014, worth a combined $63.9M — up 1.2% from $63.1M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CDMO positions and 6 closed out — a net gain of 11 holders — while 25 added to existing stakes and 25 trimmed.
The largest buyer was TFS Capital, opening a new position worth an estimated $749K. The largest seller was Sphera Funds Management, exiting entirely with an estimated $1.22M sold.
- 85 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2014, up from 74 in Q1 2014.
- Funds reported $63.9M of Avid Bioservices, Inc. Common Stock stock for Q2 2014, up 1.2% quarter-over-quarter.
- 17 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2014 and 6 closed out, a net change of +11 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2014 was TFS Capital, an estimated $749K added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2014 was Sphera Funds Management, an estimated $1.22M sold.
Based on aggregated 13F filings for Q2 2014.